Age

19–any

Sex

ALL

Healthy volunteers

Not accepted

Age ≥19 years
Histologically confirmed clinical Stage I or II cutaneous melanoma, inclusive of acral melanoma
Candidate for guideline (NCCN) concordant wide local excision
Able to provide informed consent

Trial Comparing CPDMA Versus Standard Breadloafing in WLE Specimens of Stage 1-II Cutaneous Melanoma